Clinical Trial: This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/Overweight

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017179) titled 'This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/Overweight' on May 14.

Brief Summary: This study is to assess the safety and tolerability, PK characterisation, efficacy, and immunogenicity of the study intervention, and it allows assessment of the monotherapy or combination therapy of AZD6234 and AZD9550 in different sub-studies.

Study Start Date: May 20

Study Type: INTERVENTIONAL

Condition: Obesity/Overweight

Intervention: DRUG: AZD6234

Participants will receive a subcutaneous injection weekly

DRUG: Placebo

Participants will receive a subcutaneous injection weekly.

Recruitmen...